Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CN-105 in Acute Supratentorial Intracerebral Hemorrhage
NCT03168581Phase 2Completed
- Sponsor
- AegisCN LLC
- Start
- Aug 2017
- Primary completion
- Sep 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CN-105 in intracerebral hemorrhage (ICH), sponsored by AegisCN LLC. Started Aug 2017; status: completed.
02
Drugs
CN-105
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03168581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03168581.